(17314506), R. L., (17314509), E. M., (17314512), A. L., (17314515), N. G., (17314518), I. C., (17314521), A. A., . . . (17314731), D. V. (2025). Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Chicago Style (17th ed.) Citation(17314506), Raphaël Leman, et al. Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. 2025.
MLA citiranje(17314506), Raphaël Leman, et al. Supplementary Table S4 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. 2025.